| Literature DB >> 34966202 |
Freyja Diana Ramos1, Joy Arabelle Fontanilla1,2, Reginna Emiliene Lat2.
Abstract
INTRODUCTION: Malnutrition among hospitalized patients is highly prevalent. This adversely affects outcomes with longer length of stay (LOS), higher treatment costs and increased mortality. People with diabetes mellitus (DM) are particularly vulnerable to malnutrition and its consequences.Entities:
Keywords: diabetes mellitus; hospital outcome; malnutrition
Year: 2021 PMID: 34966202 PMCID: PMC8666493 DOI: 10.15605/jafes.036.02.12
Source DB: PubMed Journal: J ASEAN Fed Endocr Soc ISSN: 0857-1074
Baseline demographics and clinical profile of patients
| Well-nourished n=71 (16.2%) | Moderately-malnourished n=221 (50.3%) | Severely-malnourished n=147 (33.5%) | Overall n=439 | ||
|---|---|---|---|---|---|
| Age, mean years ± SD | 55.9 ± 15.14 | 69.0 ± 12.70 | 70.6 ± 13.42 | 67.4 ± 14.27 | <0.001 |
| Age groups (years), n (%) | <0.001 | ||||
| Young adult (19-35) | 6 (8.5) | 3 (1.4) | 1 (0.7) | 10 (2.3) | |
| Middle aged (36-55) | 25 (35.2) | 28 (12.7) | 23 (15.6) | 76 (17.3) | |
| Older adult (56-64) | 20 (28.2) | 43 (19.5) | 23 (15.6) | 86 (19.6) | |
| Young elderly (65-74) | 7 (9.9) | 79 (35.7) | 70 (47.6) | 156 (35.5) | |
| Old elderly (>75) | 13 (18.3) | 68 (30.8) | 30 (20.4) | 111 (25.3) | |
|
| |||||
| Sex, n (%) | 0.161 | ||||
| Male | 50 (70.4) | 128 (57.9) | 92 (62.6) | 270 (61.5) | |
| Female | 21 (29.6) | 93 (42.1) | 55 (37.4) | 169 (38.5) | |
|
| |||||
| BMI, mean kg/m2 ± SD | 33.6 ± 5.23 | 27.4 ± 6.10 | 26.8 ± 6.78 | 28.2 ± 6.63 | <0.001 |
| BMI class (kg/m2), n (%) | |||||
| Normal (18.5-<25) | 3 (4.2) | 69 (31.2) | 48 (32.7) | 120 (27.3) | <0.001 |
| Underweight (<18.5) | 0 (0.0) | 9 (4.1) | 14 (9.5) | 23 (5.2) | |
| Overweight (25-<30) | 8 (11.3) | 71 (32.1) | 35 (23.8) | 114 (26.0) | |
| Obese I (30-<35) | 36 (50.7) | 51 (23.1) | 33 (22.4) | 120 (27.3) | |
| Obese II (35-<40) | 20 (28.2) | 10 (4.5) | 13 (8.8) | 43 (9.8) | |
| Obese III (>40) | 4 (5.6) | 11 (5.0) | 4 (2.7) | 19 (4.3) | |
|
| |||||
| Feeding route, n (%) | <0.001 | ||||
| Oral | 71 (100.0) | 217 (98.2) | 125 (85.0) | 413 (94.1) | |
| Enteral tube | 0 (0.0) | 4 (1.8) | 22 (15.0) | 26 (5.9) | |
|
| |||||
| Reasons for admission, n (%) | |||||
| AKI/insufficiency | 5 (7.0) | 21 (9.5) | 17 (11.6) | 43 (9.8) | 0.562 |
| Pneumonia/respiratory insufficiency | 12 (16.9) | 44 (19.9) | 35 (23.8) | 91 (20.7) | 0.456 |
| UTI | 5 (7.0) | 8 (3.6) | 6 (4.1) | 19 (4.3) | 0.460 |
| Acute GI disease | 10 (14.1) | 22 (10.0) | 16 (10.9) | 48 (10.9) | 0.624 |
| CVD | 0 (0.0) | 7 (3.2) | 5 (3.4) | 12 (2.7) | 0.301 |
| Metabolic derangement | 11 (15.5) | 12 (5.4) | 11 (7.5) | 34 (7.7) | 0.022 |
| CAD | 6 (8.5) | 18 (8.1) | 9 (6.1) | 33 (7.5) | 0.731 |
| HTN/heart failure | 9 (12.7) | 15 (6.8) | 10 (6.8) | 34 (7.7) | 0.237 |
| Skin infection | 3 (4.2) | 5 (2.3) | 8 (5.4) | 16 (3.6) | 0.269 |
| Neoplasm | 2 (2.8) | 49 (22.2) | 14 (9.5) | 65 (14.8) | <0.001 |
| Acute MS disease | 3 (4.2) | 7 (3.2) | 4 (2.7) | 14 (3.2) | 0.839 |
| Others | 5 (7.0) | 14 (6.3) | 14 (9.5) | 33 (7.5) | 0.517 |
|
| |||||
| Comorbidities, n (%) | |||||
| Without comorbidities | 8 (11.3) | 6 (2.7) | 3 (2.0) | 17 (3.9) | 0.002 |
| With comorbidities | 63 (88.7) | 215 (97.3) | 144 (98.0) | 422 (96.1) | |
| Cancer | 2 (2.8) | 85 (38.5) | 35 (23.8) | 122 (27.8) | <0.001 |
| Cardiovascular | 47 (66.2) | 166 (75.1) | 104 (70.7) | 317 (72.2) | 0.307 |
| Lung disease | 5 (7.0) | 22 (10.0) | 25 (17.0) | 52 (11.8) | 0.048 |
| Gastrointestinal | 1 (1.4) | 15 (6.8) | 10 (6.8) | 26 (5.9) | 0.213 |
| Kidney disease | 18 (25.4) | 79 (35.7) | 61 (41.5) | 158 (36.0) | 0.066 |
| Genitourinary | 3 (4.2) | 6 (2.7) | 4 (2.7) | 13 (3.0) | 0.790 |
| Endometabolic | 12 (16.9) | 22 (10.0) | 15 (10.2) | 49 (11.2) | 0.244 |
| Neurologic | 5 (7.0) | 21 (9.5) | 21 (14.3) | 47 (10.7) | 0.192 |
| Rheumatologic | 2 (2.8) | 2 (0.9) | 6 (4.1) | 10 (2.3) | 0.128 |
| Hematologic | 1 (1.4) | 3 (1.4) | 0 (0.0) | 4 (0.9) | 0.362 |
| Dermatologic | 0 (0.0) | 1 (0.5) | 0 (0.0) | 1 (0.2) | 0.610 |
|
| |||||
| Total lymphocyte count, mean mm3 ± SD | 2045.3 ± 839.09 | 1761.7 ± 1602.49 | 1889.7 ± 4356.06 | 1850.4 ± 2781.74 | 0.741 |
|
| |||||
| Albumin, mean g/dL ± SD | 3.8 ± 3.69 | 3.1 ± 0.71 | 2.8 ± 0.67 | 3.1 ± 1.64 | <0.001 |
|
| |||||
| HbA1c, mean % ± SD | 8.3 ± 2.25 | 7.2 ± 1.56 | 7.1 ± 1.65 | 7.3 ± 1.76 | <0.001 |
AKI=acute kidney injury. BMI=body mass index. CAD=coronary artery disease. CVD=cerebrovascular disease. DM=diabetes mellitus.
GI=gastrointestinal. HbA1c=glycosylated hemoglobin. HTN=hypertension. MS=musculoskeletal. UTI=urinary tract infection. SD=standard deviation.
compared using one-way analysis of variance (ANOVA) (the rest were compared using chi-square)
Length of stay and number of patients deceased according to nutritional status
| Well-nourished n=71 (16.2%) | Moderately-malnourished n=221 (50.3%) | Severely-malnourished n=147 (33.5%) | Overall n=439 | ||
|---|---|---|---|---|---|
| LOS, mean days ± SD | 4.1 ± 3.55 | 6.5 ± 6.03 | 8.3 ± 8.14 | 6.7 ± 6.66 | <0.001 |
|
| |||||
| Deceased, n (%) | 0 (0.0) | 1 (0.5) | 9 (6.1) | 10 (2.3) | 0.001 |
LOS=length of stay.
compared using one-way analysis of variance (ANOVA)
compared using chi-square
Multivariate analysis of the association between factors and length of stay (number of days)
| Beta Coefficients (95 % CI) | ||
|---|---|---|
| Body mass index | -0.2 (-0.29 – -0.10) | <0.001 |
| Normal vs severely-malnourished | 2.2 (0.49 – 3.95) | 0.012 |
| Normal vs moderately-malnourished | 1.2 (-0.40 – 2.74) | 0.142 |
Univariate analysis of the association between factors and nutritional status with mortality
| Unadjusted Odds Ratio (CI 95%) | ||
|---|---|---|
| Age group | ||
| Elderly vs non-elderly | 2.66 (0.55-12.51) | 0.209 |
|
| ||
| Sex | ||
| Male vs female | 2.55 (0.54-12.15) | 0.224 |
|
| ||
| Feeding route | ||
| Oral vs enteral tube | 0.13 (0.03-0.55) | 0.001 |
|
| ||
| BMI | ||
| Normal vs other categories | 0.95 (0.85-1.05) | 0.282 |
|
| ||
| Reasons for admission | ||
| AKI/insufficiency vs none | 1.02 (0.13-8.28) | 0.982 |
| Pneumonia/respiratory insufficiency vs none | 0.42 (0.05-3.35) | 0.397 |
| UTI vs none | - | - |
| Acute GI disease vs none | - | - |
| CVD vs none | - | - |
| Metabolic derangement vs none | 1.33 (0.16-10.85) | 0.787 |
| CAD vs none | 3.21 (0.65-15.77) | 0.130 |
| HTN/heart failure vs none | 3.10 (0.63-15.22) | 0.142 |
| Skin infection vs none | - | - |
| Neoplasm vs none | 4.02 (1.10-14.67) | 0.023 |
| Acute MS disease vs none | - | - |
| Others vs none | - | - |
|
| ||
| Co-morbidities | ||
| With vs without | 0.98 (0.96-0.99) | 0.521 |
| Cancer vs none | 1.76 (0.49-6.34) | 0.383 |
| Cardiovascular vs none | 1.55 (0.33-7.42) | 0.578 |
| Lung disease vs none | 0.82 (0.10-6.64) | 0.855 |
| Gastrointestinal vs none | 1.80 (0.22-14.74) | 0.581 |
| Kidney disease vs none | 1.80 (0.51-6.33) | 0.350 |
| Genitourinary vs none | - | - |
| Endometabolic vs none | - | - |
| Neurologic vs none | - | - |
| Rheumatologic vs none | - | - |
| Hematologic vs none | - | - |
| Dermatologic vs none | - | - |
|
| ||
| Total lymphocyte count | 1.00 (1.00 -1.00) | 0.298 |
|
| ||
| Albumin | 0.37 (0.17-0.81) | 0.013 |
|
| ||
| HbA1c | 0.86 (0.56-1.32) | 0.490 |
|
| ||
| Nutritional status | 14.35 (1.80-114.49) | 0.001 |
Association between malnutrition and mortality
| Nutritional status | Adjusted Odds Ratio (CI 95%) | |
|---|---|---|
| Severely-malnourished vs moderately-malnourished | 8.91 (1.04-76.18) | 0.046 |